{Reference Type}: Journal Article
{Title}: Molecular mechanisms of PTEN in atherosclerosis: A comprehensive review.
{Author}: Tian Y;Liu YF;Wang YY;Li YZ;Ding WY;Zhang C;
{Journal}: Eur J Pharmacol
{Volume}: 979
{Issue}: 0
{Year}: 2024 Sep 15
{Factor}: 5.195
{DOI}: 10.1016/j.ejphar.2024.176857
{Abstract}: Atherosclerosis is a chronic inflammatory disease of the arterial wall caused by an imbalance of lipid metabolism and a maladaptive inflammatory response. A variety of harmful cellular changes associated with atherosclerosis include endothelial dysfunction, the migration of circulating inflammatory cells to the arterial wall, the production of proinflammatory cytokines, lipid buildup in the intima, local inflammatory responses in blood vessels, atherosclerosis-associated apoptosis, and autophagy. PTEN inhibits the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB/AKT)/mammalian target of rapamycin (mTOR) pathway through its lipid phosphatase activity. Previous studies have shown that PTEN is closely related to atherosclerosis. This article reviews the role of PTEN in atherosclerosis from the perspectives of autophagy, apoptosis, inflammation, proliferation, and angiogenesis.